Improved Kuwaiti Health Services Urged

1 July 1997

A senior government official in Kuwait says upgrading the health serviceto international standards must take precedence over the launch of a national health insurance scheme.

Abdul Rahman Asfour, director of the Jahra Medical Complex, has said that he disapproves of the government's plan to introduce health insurance in the public sector because the base of health services in the country is lacking. He added that it was more important to improve the standards of hospitals and polyclinic services and that resources were being wasted; hospitals were overcrowded and some lacked facilities.

Mr Asfour said the government had not spelt out its plan for health insurance, but one of the main conditions in the current proposals was that those who take part in the insurance scheme cannot enjoy privileged status at government hospitals.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight